This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Instytut Farmakologii Polskiej Akademii Nauk, Jagiellonian University. Active years: 2017.
Company Filing History:



Years Active: 2017
Title: Anna Partyka: Innovator in Pyrroloquinoline Derivatives
Introduction
Anna Partyka is a notable inventor based in Kraków, Poland. She has made significant contributions to the field of pharmacology, particularly through her innovative work on pyrroloquinoline derivatives. Her research focuses on developing compounds that serve as antagonists of 5-HT6 receptors, which have potential therapeutic applications for various mental health disorders.
Latest Patents
Anna Partyka holds 1 patent related to her invention concerning pyrroloquinoline derivatives. This invention details methods for the preparation of these compounds and introduces novel intermediates useful for their synthesis. The compounds are particularly relevant for treating conditions such as schizophrenia, anxiety, depression, and several other mood and cognitive disorders. The general formula of these compounds is specified in her patent, highlighting their potential in therapeutic applications.
Career Highlights
Throughout her career, Anna Partyka has worked with esteemed institutions, including Jagiellonian University and the Institute of Pharmacology of the Polish Academy of Sciences. Her work has been instrumental in advancing the understanding of pharmacological treatments for complex disorders.
Collaborations
Anna has collaborated with notable colleagues such as Pawel Zajdel and Katarzyna Grychowska, contributing to a rich environment of research and innovation.
Conclusion
Anna Partyka's contributions to the field of pharmacology through her innovative research on pyrroloquinoline derivatives exemplify her commitment to advancing therapeutic options for mental health disorders. Her work continues to inspire future research in this critical area.